The Fibrosis Innovation Group (FIG) is modeled after highly successful innovative units within biotechnology companies and non-profit research institutes. 
The FIG streamlines and enriches existing capabilities at the Anschutz Medical Campus with a focus on fibrosis research.

Innovative units within this group:

      Cell-Based Disease Modeling Unit
      In Vivo Disease Modeling Unit
      Fibrosis Quantification Unit
      Redox Biology Unit
      Computational Biology Unit